Edge Capital Group LLC Has $331,000 Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Edge Capital Group LLC boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.3% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 744 shares of the medical equipment provider’s stock after buying an additional 44 shares during the period. Edge Capital Group LLC’s holdings in Intuitive Surgical were worth $331,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Ridgewood Investments LLC acquired a new stake in shares of Intuitive Surgical in the 2nd quarter worth about $26,000. Creekmur Asset Management LLC raised its stake in shares of Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 42 shares during the last quarter. LGT Financial Advisors LLC lifted its holdings in shares of Intuitive Surgical by 415.4% in the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 54 shares in the last quarter. Delos Wealth Advisors LLC boosted its position in shares of Intuitive Surgical by 380.0% during the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 57 shares during the last quarter. Finally, LRI Investments LLC bought a new stake in Intuitive Surgical during the first quarter worth $30,000. 83.64% of the stock is owned by institutional investors.

Insider Transactions at Intuitive Surgical

In related news, Director Amy L. Ladd sold 450 shares of the business’s stock in a transaction on Friday, September 13th. The stock was sold at an average price of $490.28, for a total transaction of $220,626.00. Following the sale, the director now directly owns 821 shares in the company, valued at approximately $402,519.88. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, Director Amy L. Ladd sold 450 shares of the business’s stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $490.28, for a total transaction of $220,626.00. Following the completion of the transaction, the director now owns 821 shares of the company’s stock, valued at $402,519.88. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Mark Brosius sold 2,115 shares of the stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $491.91, for a total transaction of $1,040,389.65. Following the completion of the sale, the insider now owns 295 shares in the company, valued at $145,113.45. The disclosure for this sale can be found here. Insiders sold 53,120 shares of company stock valued at $25,528,753 over the last three months. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Down 0.8 %

Shares of NASDAQ:ISRG opened at $486.20 on Monday. The firm has a market capitalization of $172.46 billion, a PE ratio of 87.76, a P/E/G ratio of 5.41 and a beta of 1.39. The company has a 50-day moving average price of $468.01 and a two-hundred day moving average price of $425.38. Intuitive Surgical, Inc. has a twelve month low of $254.85 and a twelve month high of $496.18.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, topping the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The company had revenue of $2.01 billion during the quarter, compared to the consensus estimate of $1.97 billion. During the same period last year, the firm earned $1.18 EPS. Intuitive Surgical’s revenue for the quarter was up 14.5% on a year-over-year basis. Analysts anticipate that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

ISRG has been the topic of several recent analyst reports. Barclays raised their price objective on Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a research note on Thursday, July 18th. Citigroup raised their price target on shares of Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research report on Thursday, August 22nd. The Goldman Sachs Group began coverage on shares of Intuitive Surgical in a report on Thursday, May 30th. They set a “buy” rating and a $500.00 price target on the stock. Morgan Stanley increased their price objective on shares of Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a research note on Monday, July 15th. Finally, Robert W. Baird boosted their target price on Intuitive Surgical from $487.00 to $503.00 and gave the stock an “outperform” rating in a research note on Friday, July 19th. Six research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $446.45.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.